Price to Book Value Chart

View Price to Book Value for AGIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
August 21, 2026 1.922
August 20, 2026 1.954
August 19, 2026 2.040
August 18, 2026 1.998
August 17, 2026 1.954
August 14, 2026 1.950
August 13, 2026 1.944
August 12, 2026 1.987
August 11, 2026 1.899
August 10, 2026 1.893
August 07, 2026 1.875
August 06, 2026 1.856
August 05, 2026 1.843
August 04, 2026 1.836
August 03, 2026 1.774
July 31, 2026 1.744
July 30, 2026 1.903
July 29, 2026 2.034
July 28, 2026 2.091
July 27, 2026 2.148
July 24, 2026 2.112
July 23, 2026 2.108
July 22, 2026 2.094
July 21, 2026 2.170
July 20, 2026 2.327
Date Value
July 17, 2026 2.301
July 16, 2026 2.249
July 15, 2026 2.316
July 14, 2026 2.319
July 13, 2026 2.356
July 10, 2026 2.395
July 09, 2026 2.486
July 08, 2026 2.484
July 07, 2026 2.557
July 06, 2026 2.172
July 02, 2026 2.183
July 01, 2026 2.154
June 30, 2026 2.156
June 29, 2026 2.035
June 26, 2026 2.028
June 25, 2026 1.937
June 24, 2026 1.941
June 23, 2026 1.904
June 22, 2026 1.878
June 18, 2026 1.828
June 17, 2026 1.770
June 16, 2026 1.704
June 15, 2026 1.702
June 12, 2026 1.576
June 11, 2026 1.537

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 3.903
Biogen, Inc. 1.709
Insmed, Inc. 35.74
Liquidia Corp. 32.09
Alnylam Pharmaceuticals, Inc. 23.31

Price to Book Value Related Metrics

PS Ratio 19.45
Price 32.60
Earnings Yield -21.50%
Market Cap 1.943B